(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 7. Cooperation between Otx1 and Otx2 under FM and FM2
enhancers. (A) Histological features of a series of double mutants at E12.5;
the genotype of each mutant is indicated at the left. Among mutants not shown,
defects were either absent or subtle in
Otx2
FM2/
FM2,
Otx1+/Otx2+/
FM2,
Otx1/,
Otx2+/,
Otx2
FM/
FM2,
Otx1+/Otx2+/
FM,
Otx2
FM/
FM,
Otx1+/Otx2
FM2/
FM2 and
Otx1/Otx2+/
FM2 mutants.
Otx1+/Otx2
FM2/ was
affected to the same extent as Otx2
FM/ (f);
furthermore, defects in
Otx1+/Otx2
FM/ were as
severe as those in
Otx1/Otx2
FM/
FM (h).
Arrowheads indicate the position of the isthmus. Scale bars: 400 µm. (B)
Marker analysis of the defects in
Otx1/Otx2
FM/
FM at
E10.5; Otx2 (a), Pax6 (b), Fgf8 (c) and
Emx2 (d) expression. See Fig.
3C for the expression in wild-type embryos. Arrows in a and b
indicate residual Otx2- and Pax6-positive domains,
respectively. Scale bars: 400 µm.